PUT - SPRINTER OPEN END - BIOGEN IDEC | Market Closed - Deutsche Boerse AG 14:02:32 2024-06-14 EDT | ||
| 6.47 EUR | +3.52% |
|
| Current month | -6.91% | ||
| 1 month | -5.96% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-06-14 | 6.47 | +3.52% |
| 24-06-13 | 6.25 | -4.29% |
| 24-06-12 | 6.53 | -4.11% |
| 24-06-11 | 6.81 | +1.49% |
| 24-06-10 | 6.71 | -0.45% |
Delayed Quote Deutsche Boerse AG
Last update June 14, 2024 at 02:02 pm
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | BIOGEN INC. |
| Issuer | 
Vontobel
|
| WKN | VU81BV |
| ISIN | DE000VU81BV3 |
| Date issued | 2023-06-26 |
| Strike | 297.5 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.92 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 10.18 € |
|---|---|
| Lowest since issue | 0.65 € |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
231.7
USD
Average target price
284.6
USD
Spread / Average Target
+22.85%
- Stock Market
- Certificates
- Certificat
